Risk factors

TSANZ ‘no’ to e-cigs: pharmacotherapy first for patients who want to quit

Clinicians should ‘hold the line’ on e-cigarettes as a tool for smoking cessation and instead continue to recommend existing pharmacotherapy and qualified behavioural support for patients wanting to quit. The advice forms part of the Thoracic Society of Australia and New Zealand’s (TSANZ) draft position on the health impacts of the controversial products and their ...

Already a member?

Login to keep reading.

© 2022 the limbic